Digital Health Weekly: 25– 31 December, 2025
Machine learning identifies key immune-inflammatory genes paving the way for repurposed drugs to treat drug-resistant epilepsy A new study published in Scientific Reports utilizes explainable machine learning to uncover critical biomarkers associated with drug-resistant epilepsy (DRE), a condition that affects nearly one-third of all epilepsy patients. Researchers applied advanced algorithms to transcriptomic data, identifying specific immune-inflammatory genes that drive the resistance mechanism. By isolating these genetic drivers, the model was not only able to distinguish DRE patients from responsive ones with high accuracy but also pinpointed potential therapeutic targets that have been overlooked by traditional research methods. The most promising outcome of this research is the identification of existing, FDA-approved drugs that could be repurposed to target these specific immune pathways. The machine learning analysis highlighted several candidate compounds originally designed ...